Drug · DIN 02244081
PREVNAR
SINGLE-DOSE PREFILLED SYRINGES AND VIALS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 2, 2017; first marketed June 20, 2001.
- Drug Identification Number (DIN)
- 02244081
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Schedule D
- Dosage form
- Suspension
- Route
- Intramuscular
- Therapeutic class (ATC)
- Pneumococcus, purified polysacc.antigen conjugated J07AL02
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 | 2 MCG | 0.5 ML |
| PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V | 2 MCG | 0.5 ML |
| PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 | 2 MCG | 0.5 ML |
| PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C | 2 MCG | 0.5 ML |
| PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F | 2 MCG | 0.5 ML |
| PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F | 2 MCG | 0.5 ML |
| PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B | 4 MCG | 0.5 ML |
| CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN | 20 MCG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 7, 2010: NOC 11794New Drug Submission (NDS) · Manufacturer name change
- April 8, 2003: NOC 3579New Drug Submission (NDS) · Manufacturer name change
- June 7, 2001: NOC 2125New Drug Submission (NDS)